The first person with coronavirus disease 2019 (COVID-19) complicating pulmonary hypertension (PH) has received at-home treatment with inhaled nitric oxide (iNO), delivered through the Genosyl system, according to VERO Biotech, manufacturer of Genosyl. Read more: https://pulmonaryhypertensionnews.com/2020/03/25/covid-19-patient-with-ph-treated-with-ino-via-genosyl-vero-biotech-announces/

Company, staff, talent, and clients donate to NAACP Legal Defense and Educational Fund.   In the wake of the killings of George Floyd, Breonna Taylor, and too many others, Aquent committed to donating $20,000 to the NAACP Legal [...]

Company's Organic Revenue Growth Has Fueled 48% CAGR from 2014 through 2020, New Members of Exec Team Include Chief Data Officer from Google and DataFoundry, President of PureB2B Division, and GM for its U.S. Analytics Business DANVERS, Mass., [...]

Galmedica will Sell and Support a Full Line of Non-Invasive High-Tech Thermometers for use in Hospitals and Healthcare Institutions Exergen Corporation, a global leader in infrared temperature measurement technologies for medical applications, announced today that it has signed [...]

Dynasil Corporation of America (“Dynasil” or the “Company”), a leading developer and manufacturer of optics and photonics products, optical detection and analysis technology and components for the homeland security, medical and industrial markets, today announces that CLLBC, a [...]